Docetaxel, Cisplatin
Sponsors
National Taiwan University Hospital, Spanish Lung Cancer Group, National Cancer Center, Korea, Samsung Medical Center
Conditions
BRCA1 MutationGastric CancerNasopharyngeal CancerNon Small Cell Lung CancerNon-small Cell Lung Cancer
Phase 2
Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)
CompletedNCT00173888
Start: 2003-07-31End: 2012-11-30Updated: 2012-12-06
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer
NCT00980603
Start: 2008-11-30End: 2011-05-31Target: 144Updated: 2009-09-21
Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer
NCT01312311
Start: 2006-07-31Target: 51Updated: 2011-03-10